(redirected from Vagus nerve stimulation)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
References in periodicals archive ?
Henry TR, Bakay RAE, Votaw JR, et al: Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I.
The INOVATE-HF study is an important pivotal trial that may ultimately position vagus nerve stimulation as a valuable new therapeutic option for patients with HF," said Dr.
electroCore LLC, the New Jersey based bioelectric pharma company, is focused on developing non-invasive vagus nerve stimulation therapies (the gammaCore device) for the treatment of multiple conditions in neurology, psychiatry, gastroenterology, and respiratory fields.
The recent study suggested that pairing vagus nerve stimulation with standard therapy may result in more rapid and extensive reorganization of the brain, offering the potential for speeding and improving recovery following stroke, said Rennaker, associate professor in The University of Texas at Dallas' School of Behavioral and Brain Sciences
Table 3 Vagus nerve stimulation treatment parameters Parameter Units Range Output current Milliamps (mA) 0 to 3.
Vagus nerve stimulation (VNS) is now approved for two indications: drug-refractory epilepsy and drug-refractory depression.
Cyberonics was founded in 1987 to design, develop and market medical devices for the long-term treatment of epilepsy and other chronic neurological disorders using a unique therapy, vagus nerve stimulation (VNS).
Vagus nerve stimulation was approved in 1997 for treating epilepsy Later reports suggested that seizure control improves the longer a patient has the device.
Abstract: Vagus nerve stimulation was recently approved for control of medically intractable seizures.
YEHUD, Israel -- BioControl Medical has announced that the FitNeS[TM] implantable vagus nerve stimulation system for treating epilepsy, which employs the same platform technology used in the company's CardioFit([R]) system for treating congestive heart failure, has been shown effective in initial cases performed at Sahlgrenska University Hospital, Gothenburg, Sweden.
com)-- In a multi-centered, sham-controlled study conducted in the United States, episodic cluster headache patients using the gammaCore non-invasive vagus nerve stimulation device (nVNS) had a significant and clinically meaningful benefit within 15 minutes of the treatment of the attack, as compared with the sham treatment, and that this benefit was sustained for over an hour.